Paul Allen Seligman
Physician at 19 Ave, Denver, CO
License number
Colorado 21841
Issued Date
Jul 11, 1978
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
12700 E 19Th Ave RM 9122-RC2 - CAMPUS BOX B170, Denver, CO 80045
Professional information
Paul Seligman, Aurora CO
Work:
Univ. Of Co.
12700 E 19 Ave, Aurora, CO 80045 University of Colorado
4200 E 9Th Ave, Denver, CO 80220 University Physicians Inc. - Outpatient Pavilion - Anschutz Centers For Advanced Medicine
1635 Aurora Ct, Aurora, CO 80045 Paul A Bunn
1772 Platte St, Denver, CO 80202
12700 E 19 Ave, Aurora, CO 80045 University of Colorado
4200 E 9Th Ave, Denver, CO 80220 University Physicians Inc. - Outpatient Pavilion - Anschutz Centers For Advanced Medicine
1635 Aurora Ct, Aurora, CO 80045 Paul A Bunn
1772 Platte St, Denver, CO 80202
Dr. Paul Seligman - MD (Doctor of Medicine)
Hospitals:
1665 Aurora Ct, Aurora 80045
4200 E 9Th Ave, Denver 80262
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16 Ave, Aurora 80045
1665 Aurora Ct, Aurora 80045
4200 E 9Th Ave, Denver 80262
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16 Ave, Aurora 80045
4200 E 9Th Ave, Denver 80262
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16 Ave, Aurora 80045
1665 Aurora Ct, Aurora 80045
4200 E 9Th Ave, Denver 80262
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16 Ave, Aurora 80045
Education:
Medical Schools
University At Buffalo State University Of New York School Of Medicine
Graduated: 1972
University At Buffalo State University Of New York School Of Medicine
Graduated: 1972
Immunoassay For Measurement Of Reticulocytes, And Immunoreactive Reagents For Use Therein
US Patent:
4447547, May 8, 1984
Filed:
Mar 9, 1982
Appl. No.:
6/356539
Inventors:
Robert H. Allen - Englewood CO
Paul A. Seligman - Denver CO
Paul A. Seligman - Denver CO
Assignee:
University Patents, Inc. - Norwalk CT
International Classification:
G01N 3354, G01N 3358, G01N 3360
US Classification:
436543
Abstract:
The reticulocyte content present in a specimen of red blood cells is quantitatively measured based upon the selective immunoreactivity of the reticulocyte portion of the specimen with a reticulocyte-specific antibody which is immunoreactive with proteinaceous material associated with reticulocytes but not associated with mature red blood cells. Such immunoreactive proteinaceous material may be transferrin, transferrin receptor, transcobalamin II, or transcobalamin II receptor. Various procedures are described for quantitating such selective immunoreactivity, including fluorescent and radioactive detection techniques employing direct or indirect fluorescent or radioactive labeling of the reticulocyte-specific antibody.
Immunoassay For Measurement Of Reticulocytes, And Immunoreactive Reagents For Use Therein
US Patent:
4332785, Jun 1, 1982
Filed:
Apr 9, 1980
Appl. No.:
6/138785
Inventors:
Robert H. Allen - Englewood CO
Paul A. Seligman - Denver CO
Paul A. Seligman - Denver CO
Assignee:
University Patents, Inc. - Norwalk CT
International Classification:
G01N 3356, G01N 3358
US Classification:
424 1
Abstract:
The reticulocyte content present in a specimen of red blood cells is quantitatively measured based upon the selective immunoreactivity of the reticulocyte portion of the specimen with a reticulocyte-specific antibody which is immunoreactive with proteinaceous material associated with reticulocytes but not associated with mature red blood cells. Such immunoreactive proteinaceous material may be transferrin, transferrin receptor, transcobalamin II, or transcobalamin II receptor. Various procedures are described for quantitating such selective immunoreactivity, including fluorescent and radioactive detection techniques employing direct or indirect fluorescent or radioactive labeling of the reticulocyte-specific antibody.